DCI Indonesia Tbk vs Ikapharmindo Putramas Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp183,900 (market cap 473.59T, 200 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 308.29B, 400 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 1536.2× Ikapharmindo Putramas Tbk.'s market cap, and Ikapharmindo Putramas Tbk. is more actively traded (400 versus 200). Which is the better fit depends on your goals.
| DCII | IKPM | |
|---|---|---|
Market Cap | 473.59T | 308.29B |
Volume | 200 | 400 |
Lot | 2 | 4 |
Turnover | 36.35M | 73.2K |
Average Price | 181,737.5 | 183 |
Value | 36.35M | 73.2K |
Indicative Equilibrium Price | — | 183 |
Indicative Equilibrium Volume | — | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →